Key takeaways:
Ozempic (semaglutide) is a medication used to treat Type 2 diabetes. Under the brand name Wegovy, it’s also used for weight management in some people.
There’s some evidence linking semaglutide to depression and suicidal thoughts. But in other studies, there wasn’t really a clear connection.
More research is needed to understand how semaglutide and other GLP-1 agonists affect mental health.
Ozempic (semaglutide) is a type of injectable medication called a GLP-1 agonist. It’s approved by the FDA for Type 2 diabetes, and has been shown to lower blood glucose, improve hemoglobin A1C (HbA1c or A1C), and cause weight loss. Semaglutide is also prescribed as Wegovy, an injectable medication for weight loss, as well as Rybelsus, an oral medication, to treat Type 2 diabetes.
Ozempic and other similar medications have become increasingly popular. But there are lingering concerns — including whether there’s a link between semaglutide, depression, and suicidal thoughts. Let’s take a closer look at what research shows at this point.
So far, both the European Medicines Agency (EMA) and the FDA have concluded that GLP-1 agonists — including semaglutide — do not cause suicidal thoughts. But there’s mixed evidence about whether there’s a link. This is an important distinction to make. A link is just the first step toward proving that something causes a specific health outcome. A link alone does not prove that there’s a cause-and-effect relationship.
Here’s the data that’s available so far. A new study based on a World Health Organization (WHO) database was published in August 2024. In this study, researchers found an increased risk of suicidal thoughts in people taking semaglutide compared to other diabetes medications. This was especially true for people who were also taking antidepressants. But the overall risk was still low.
However, other reports tell a different story. A large study from February 2024 looked at over 4 million people with and without diabetes. It found that people using semaglutide actually had lower rates of depression and anxiety than baseline. In another large study from January 2024, semaglutide was linked to a lower risk of suicidal thoughts in people who have Type 2 diabetes or are considered overweight or obese.
As people continue to use semaglutide, the FDA and WHO will continue to monitor for adverse events — and update the general public as needed. In the meantime, the FDA urges healthcare professionals and anyone using Ozempic, Wegovy, or Rybelsus to watch for symptoms of depression, suicidal thoughts, or any other changes in mood or behavior.
It’s possible. But again, it’s a complex topic.
For example, in clinical trials, a small number of people taking Saxenda (liraglutide) and Wegovy (semaglutide) experienced suicidal thoughts. As a result, the company that makes Saxenda and Wegovy currently lists “depression or thoughts of suicide” as a possible side effect for these medications. But they do not list it as a side effect for Ozempic (semaglutide).
The August 2024 study mentioned above also found a link between semaglutide and suicidal thoughts. But they didn’t specify if this was for Wegovy or Ozempic. And the researchers also did not find the same link with liraglutide.
So, what’s the bottom line? At this point, the FDA and the EMA say that GLP-1 agonists do not cause suicidal thoughts. This includes many other GLP-1 agonists not mentioned in this article, like dulagutide and exenatide.
But remember: These are just preliminary conclusions. As the FDA and other organizations continue to gather more information about GLP-1 agonists, the scientific community will learn more about any potential connection between these medications, depression, and suicidal thoughts. In other words, time will tell.
It’s hard to say. Research is ongoing to see if semaglutide causes depression directly, or if the two are linked by another cause, or if it’s simply through coincidence.
For example, many people who use Ozempic, Wegovy, or Rybelsus are already at greater risk for depression before they start these medications. That’s because both diabetes and excess weight are linked to depression.
Depression itself is also a common illness. In fact, in the U.S., close to 1 in 10 people will have a major depression episode at some point during their life. This means that as more and more people start using semaglutide, more and more people who use it will also experience depression, simply because depression is so widespread.
It’s not clear that Ozempic does cause depression. But some people may notice symptoms of depression while using this medication.
Common symptoms of depression are:
Low mood
Loss of pleasure
Sleep changes
Restlessness or slowness
Fatigue or low energy
Feelings of worthlessness or guilt
Trouble thinking clearly
Loss of appetite or weight loss
Suicidal ideation, or thoughts about death
If you have any of these symptoms, talk to a healthcare professional. They’ll help you figure out what’s causing your symptoms, and whether you need to stop using Ozempic.
It depends. There’s no FDA warning that cautions against using Ozempic if you have depression. And so far there’s no clear evidence that using Ozempic will make your depression worse.
That being said, it's still a good idea to carefully watch for any changes in your mood when using Ozempic — especially if you have a history of depression. If you begin to notice any changes, talk to a healthcare professional as soon as possible.
There’s no clear-cut connection between Ozempic and anxiety. Some people using Ozempic have reported anxiety as a side effect. But there’s also some evidence that anxiety may actually be less likely in people using Ozempic.
Researchers and government organizations continue to investigate if there’s a link. But, just like with depression, it’s difficult because people living with diabetes or excess weight are already more likely to have anxiety or other mood disorders in general.
Ozempic is generally easy to use, but it can cause side effects in some people. Common side effects include:
Nausea or vomiting
Diarrhea or constipation
Abdominal pain
Headache
Tiredness
Dizziness
Heartburn or indigestion
More serious risks may include:
Gallstones
Kidney damage
Symptomatic low blood sugar
Fast heart rate
Ozempic shouldn’t be taken by people at risk for certain thyroid cancers or who are allergic to its ingredients. Talk with your healthcare professional about your risk of taking Ozempic based on your medical history.
Some people who take Ozempic have reported mood changes, sometimes called “Ozempic personality” by the media. But in reality, there’s not a lot of evidence to support this. Though Ozempic can potentially change how you think about food, there’s no evidence that it will change your personality.
No. In fact, there’s a small amount of evidence that Ozempic and similar medications might actually help to slow down Alzheimer’s disease. Large research studies are currently underway to better understand what medications like Ozempic do to your brain, and how they might potentially help protect it over time.
Ozempic mimics a hormone in your body called GLP-1. This is a hormone that’s naturally released in your gut when you eat. It sends signals to your brain (and other parts of your body) that it’s time to stop eating. As a result, many people taking Ozempic eat less often and feel less interested in food.
Ozempic and similar medications are helpful tools for managing diabetes, weight, and much more. There are some reports of depression and suicidal thoughts in people using Ozempic. Nonetheless, there’s no clear evidence that Ozempic is the direct cause. More data is needed before we can say for sure. All the same, if you experience depression or suicidal thoughts while using Ozempic, talk to a healthcare professional as soon as possible.
If you or someone you know is having thoughts of suicide, you’re not alone, and help is available. Call the National Suicide Prevention Lifeline at 988, or text HOME to 741-741 to reach the Crisis Text Line.
For additional resources or to connect with mental health services in your area, call the National Helpline of the Substance Abuse and Mental Health Services Administration (SAMHSA) at 1-800-662-HELP (4357).
Borgland, S. L. (2021). Can treatment of obesity reduce depression or vice versa? Journal of Psychiatry & Neuroscience.
Centers for Disease Control and Prevention. (2022). Consequences of obesity.
Centers for Disease Control and Prevention. (2024). Diabetes and mental health.
Doctrow, B. (2024). People taking semaglutide had lower risk of suicidal thoughts. National Institutes of Health.
European Medicines Agency. (2024). Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2024.
Lupkin, S., et al. (2023). As Ozempic use grows, so do reports of possible mental health side effects. NPR.
Miller, A, et al. (2024). Most GLP-1 medications correlated with a lower likelihood of anxiety and depression diagnoses. Epic Research.
National Institute of Mental Health. (2023). Major depression.
Novo Nordisk. (n.d.). Common side effects of Wegovy.
Novo Nordisk. (n.d.). Possible side effects of Ozempic (semaglutide) injection.
Novo Nordisk. (n.d.). Understanding Saxenda side effects.
Panda, S. S., et al. (2023). A systematic review on the association between obesity and mood disorders and the role of gut microbiota. Metabolites.
Schoretsanitis, G., et al. (2024). Disproportionality analysis from World Health Organization Data on semaglutide, liraglutide, and suicidality. JAMA Network Open.
Tirrell, M. (2024). Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial. CNN Health.
U.S. Food and Drug Administration. (2024). Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.